Current Status and Prospects for Gene and Cell Therapeutics for Type 1 Diabetes Mellitus

Reviews in Endocrine and Metabolic Disorders

Volumn 4, Issue 4, 2003, Pages 369-380

  Giannoukakis, Nick ^a   Trucco, Massimo ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Gene therapy; Immunoregulators; Type 1 diabetes; Vectors

Indexed keywords

AUTOANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON RECEPTOR; GLUTAMATE DECARBOXYLASE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY CD3; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ADOPTIVE IMMUNOTHERAPY; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL IMMORTALIZATION; CLINICAL TRIAL; DENDRITIC CELL; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGENICITY; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PROTEIN TARGETING; REVIEW; STEM CELL; THYMUS; VIRAL GENE THERAPY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 0344738831     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027306213563     Document Type: Review

References (217)

1. Berney T, Buhler L, Caulfield A, Oberholzer J, Toso C, Alejandro R, Cooper DK, Ricordi C, Morel P. Transplantation of islets of Langerhans: New developments. Swiss Med Wkly 2001;131:671-680.
2. Boker A, Rothenberg L, Hernandez C, Kenyon NS, Ricordi C, Alejandro R. Human islet transplantation: Update. World J Surg 2001;25:481-486.
3. Berney T, Ricordi C. Islet cell transplantation: The future? Langenbecks. Arch Surg 2000;385:373-378.
4. Berney T, Ricordi C. Islet transplantation. Cell Transplant 1999;8:461-464.
5. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710-719.
6. Ryan EA, Lakey JR, Shapiro AM. Clinical results after islet transplantation. J Investig Med 2001;49:559-562.
7. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
8. Giannoukakis N, Rudert WA, Robbins PD, Trucco M. Targeting autoimmune diabetes with gene therapy. Diabetes 1999;48:2107-2121.
9. Giannoukakis N, Thomson A, Robbins P. Gene therapy in transplantation. Gene Ther 1999;6:1499-1511.
10. Bottino R, Trucco M, Balamurugan AN, Starzl TE. Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol 2002;16:457-474.
11. Bottino R, Balamurugan AN, Giannoukakis N, Trucco M. Islet/pancreas transplantation: Challenges for pediatrics. Pediatric Diabetes 2002;3:210.
12. Balamurugan AN, Chang Y, Fung JJ, Trucco M, Bottino R. Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata. Am J Transplant 2003;3:1135-1142.
13. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002;99:5515-5520.
14. Kogure K, Urabe M, Mizukami H, Kume A, Sato Y, Monahan J, Ozawa K. Targeted integration of foreign DNA into a defined locus on chromosome 19 in K562 cells using AAV-derived components. Int J Hematol 2001;73:469-475.
15. Pieroni L, Fipaldini C, Monciotti A, Cimini D, Sgura A, Fattori E, Epifano O, Cortese R, Palombo F, La Monica N. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 1998;249:249-259.
16. Ikeda Y, Collins MK, Radcliffe PA, Mitrophanous KA, Takeuchi Y. Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther 2002;9:932-938.
17. O'Rourke JP, Newbound GC, Kohn DB, Olsen JC, Bunnell BA. Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors. J Virol 2002;76:1510-1515.
18. Olsen JC. Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 1998;5:1481-1487.
19. Lotery AJ, Derksen TA, Russell SR, Mullins RF, Sauter S, Affatigato LM, Stone EM, Davidson BL. Gene transfer to the non-human primate retina with recombinant feline immunodeficiency virus vectors. Hum Gene Ther 2002;13:689-696.
20. Kelly PF, Vandergriff J, Nathwani A, Nienhuis AW, Vanin EF. Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD 114) envelope protein. Blood 2000;96:1206-1214.
21. Curran MA, Kaiser SM, Achacoso PL, Nolan GP. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther 2000;1:31-38.
22. Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 1998;4:354-357.
23. Britt LD, Scharp DW, Lacy PE, Slavin S. Transplantation of islet cells across major histocompatibility barriers after total lymphoid irradiation and infusion of allogeneic bone marrow cells. Diabetes 1982;31 (Suppl 4):63-68.
24. Exner BG, Fowler K, Ildstad ST. Tolerance induction for islet transplantation. Ann Transplant 1997;2:77-80.
25. Rossini AA, Parker DC, Phillips NE, Durie FH, Noelle RJ, Mordes JP, Greiner DL. Induction of immunological tolerance to islet allografts. Cell Transplant 1996;5:49-52.
26. Domenick MA, Ildstad ST. Impact of bone marrow transplantation on type I diabetes World. J Surg 2001;25:474-480.
27. Good RA, Verjee T. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities. Biol Blood Marrow Transplant 2001;7:123-135.
28. Mathieu C, Bouillon R, Rutgeerts O, Waer M. Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: Experience in the NOD model. Transplant Proc 1995;27:640-641.
29. Mathieu C, Vandeputte M, Bouillon R, Waer M. Protection against autoimmune diabetes by induction of mixed bone marrow chimerism. Transplant Proc 1993;25:1266-1267,
30. Li H, Kaufman CL, Ildstad ST. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 1995;118:192-197; discussion 197-198.
31. Li H, Inverardi L, Ricordi C. Chimerism-induced remission of overt diabetes in nonobese diabetic mice. Transplant Proc 1999;31:640.
32. Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Styche AJ, Trucco M. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes. Cell Transplant 2002;11:113-123.
33. Zorina TD, Subbotin VM, Bertera S, Alexander A, Haluszczak C, Styche AJ, Gambrell B, Bottino R, Trucco M. Recovery of endogenous beta cell function in autoimmune diabetes Stem Cells 2003;21:377-388.
34. Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999;48:2300-2308.
35. Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992;90:741-748.
36. Giannoukakis N, Bonham CA, Qian S, Chen Z, Peng L, Harnaha J, Li W, Thomson AW, Fung JJ, Robbins PD, Lu L. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther 2000;1:430-437.
37. Lu L, Thomson AW. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002;73:S19-22.
38. Lu L, Gambotto A, Lee WC, Qian S, Bonham CA, Robbins PD, Thomson AW. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther 1999;6:554-563.
39. Lu L, Lee WC, Takayama T, Qian S, Gambotto A, Robbins PD, Thomson AW. Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig). J Leukoc Biol 1999;66:293-296.
40. Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: Implications for transplantation. Transplantation 1999;68:1-8.
41. Lee WC, Zhong C, Qian S, Wan Y, Gauldie J, Mi Z, Robbins PD, Thomson AW, Lu L. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta. Transplantation 1998;66:1810-1817.
42. Takayama T, Nishioka Y, Lu L, Lotze MT, Tahara H, Thomson AW. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 1998;66:1567-1574.
43. Cornelius JG, Tchernev V, Kao KJ, Peck AB. In vitro-generation of islets in long-term cultures of pluripotent stem cells from adult mouse pancreas. Horm Metab Res 1997;29:271-277.
44. Beattie GM, Rubin JS, Mally MI, Otonkoski T, Hayek A. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes 1996;45:1223-1228.
45. Beattie GM, Lopez AD, Hayek A. In vivo maturation and growth potential of human fetal pancreases: Fresh versus cultured tissue. Transplant Proc 1995;27:3343.
46. Beattie GM, Hayek A. Outcome of human fetal pancreatic transplants according to implantation site. Transplant Proc 1994;26:3299.
47. Beattie GM, Cirulli V, Lopez AD, Hayek A. Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab 1997;82:1852-1856.
48. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001;292:1389-1394.
49. Wagers AJ, Christensen JL, Weissman IL. Cell fate determination from stem cells. Gene Ther 2002;9:606-612.
50. McKay R. Stem cells - Hype and hope. Nature 2000;406:361-364.
51. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA. Insulin staining of ES cell progeny from insulin uptake. Science 2003;299:363.
52. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
53. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, Lenvik T, Johnson S, Hu WS, Verfaillie CM. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-1302.
54. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann NY Acad Sci 2001;938:231-233; discussion 233-235.
55. Colman A, Kind A. Therapeutic cloning: Concepts and practicalities. Trends Biotechnol 2000;18:192-196.
56. Kind A, Colman A. Therapeutic cloning: Needs and prospects Semin. Cell Dev Biol 1999;10:279-286.
57. Lanza RP, Cibelli JB, West MD. Human therapeutic cloning. Nat Med 1999;5:975-977.
58. Simerly C, Dominko T, Navara C, Payne C, Capuano S, Gosman G, Chong KY, Takahashi D, Chace C, Compton D, Hewitson L, Schatten G. Molecular correlates of primate nuclear transfer failures. Science 2003;300:297.
59. D'Ambra R, Surana M, Efrat S, Starr RG, Fleischer N. Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology 1990;126:2815-2822.
60. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 1995;92:3576-3580.
61. Efrat S. Cell-based therapy for insulin-dependent diabetes mellitus. Eur J Endocrinol 1998;138:129-133.
62. Fleischer N, Chen C, Surana M, Leiser M, Rossetti L, Pralong W, Efrat S. Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 1998;47:1419-1425.
63. Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS. Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes 1995;44:1458-1460.
64. Otonkoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994;43:947-953.
65. Otonkoski T, Cirulli V, Beattie M, Mally MI, Soto G, Rubin JS, Hayek A. A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. Endocrinology 1996;137:3131-3139.
66. Levine F, Leibowitz G. Towards gene therapy of diabetes mellitus. Mol Med Today 1999;5:165-171.
67. Beattie GM, Itkin-Ansari P, Cirulli V, Leibowitz G, Lopez AD, Bossie S, Mally MI, Levine F, Hayek A. Sustained proliferation of PDX-1+cells derived from human islets. Diabetes 1999;48:1013-1019.
68. Habener JF, Stoffers DA. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Physicians 1998;110:12-21.
69. Madsen OD, Jensen J, Petersen HV, Pedersen EE, Oster A, Andersen FG, Jorgensen MC, Jensen PB, Larsson LI, Serup P. Transcription factors contributing to the pancreatic beta-cell phenotype Horm. Metab Res 1997;29:265-270.
70. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med 1997;75:327-340.
71. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000;6:568-572.
72. Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R. Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 1997;17:6002-6013.
73. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med 1997;75:327-340.
74. Oster A, Jensen J, Serup P, Galante P, Madsen OD, Larsson LI. Rat endocrine pancreatic development in relation to two homeobox gene products (Pdx-1 and Nkx 6.1). J Histochem Cytochem 1998;46:707-715.
75. Hill DJ, Hogg J. Growth factor control of pancreatic B cell hyperplasia Baillieres. Clin Endocrinol Metab 1991;5:689-698.
76. Ilieva A, Yuan S, Wang RN, Agapitos D, Hill DJ, Rosenberg L. Pancreatic islet cell survival following islet isolation: The role of cellular interactions in the pancreas (In Process Citation). J Endocrinol 1999;161:357-364.
77. Miettinen PJ, Otonkoski T, Voutilainen R. Insulin-like growth factor-II and transforming growth factor-alpha in developing human fetal pancreatic islets. J Endocrinol 1993;138:127-136.
78. Petrik J, Arany E, McDonald TJ, Hill DJ. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 1998;139:2994-3004.
79. Petrik J, Pell JM, Arany E, McDonald TJ, Dean WL, Reik W, Hill DJ. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 1999;140:2353-2363.
80. Markoff E, Beattie GM, Hayek A, Lewis UJ. Effects of prolactin and glycosylated prolactin on (pro)insulin synthesis and insulin release from cultured rat pancreatic islets. Pancreas 1990;5:99-103.
81. Kawai M, Kishi K. In vitro studies of the stimulation of insulin secretion and B-cell proliferation by rat placental lactogen-II during pregnancy in rats. J Reprod Fertil 1997;109:145-152.
82. Billestrup N, Nielsen JH. The stimulatory effect of growth hormone, prolactin, and placental lactogen on beta-cell proliferation is not mediated by insulin-like growth factor-I. Endocrinology 1991;129:883-888.
83. Vasavada RC, Cavaliere C, D'Ercole AJ, Dann P, Burtis WJ, Madlener AL, Zawalich K, Zawalich W, Philbrick W, Stewart AF. Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J Biol Chem 1996;271:1200-1208.
84. Porter SE, Sorenson RL, Dann P, Garcia-Ocana A, Stewart AF, Vasavada RC. Progressive pancreatic islet hyperplasia in the islet-targeted, parathyroid hormone-related protein-overexpressing mouse. Endocrinology 1998;139:3743-3751.
85. Wang RN, Rehfeld JF, Nielsen FC, Kloppel G. Expression of gastrin and transforming growth factor-alpha during duct to islet cell differentiation in the pancreas of duct-ligated adult rats. Diabetologia 1997;40:887-893.
86. Miettinen PJ, Otonkoski T, Voutilainen R. Insulin-like growth factor-II and transforming growth factor-alpha in developing human fetal pancreatic islets. J Endocrinol 1993;138:127-136.
87. Miettinen PJ. Transforming growth factor-alpha and epidermal growth factor expression in human fetal gastrointestinal tract. Pediatr Res 1993;33:481-486.
88. Baeza N, Hart A, Ahlgren U, Edlund H. Insulin promoter factor-1 controls several aspects of beta-cell identity. Diabetes 2001;50(Suppl 1):S36.
89. Hart AW, Baeza N, Apelqvist A, Edlund H. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature 2000;408:864-868.
90. Yamaoka T, Itakura M. Development of pancreatic islets (review). Int J Mol Med 1999;3:247-261.
91. Mally MI, Otonkoski T, Lopez AD, Hayek A. Developmental gene expression in the human fetal pancreas. Pediatr Res 1994;36:537-544.
92. Unno M, Itoh T, Watanabe T, Miyashita H, Moriizumi S, Teraoka H, Yonekura H, Okamoto H. Islet beta-cell regeneration and reg genes. Adv Exp Med Biol 1992;321:61-66.
93. Zenilman ME, Chen J, Danesh B, Zheng QH. Characteristics of rat pancreatic regenerating protein. Surgery 1998;124:855-863.
94. Zenilman ME, Chen J, Magnuson TH. Effect of reg protein on rat pancreatic ductal cells. Pancreas 1998;17:256-261.
95. Bone AJ, Banister SH, Zhang S. The REG gene and islet cell repair and renewal in type 1 diabetes. Adv Exp Med Biol 1997;426:321-327.
96. Vinik A, Rafaeloff R, Pittenger G, Rosenberg L, Duguid W. Induction of pancreatic islet neogenesis. Horm Metab Res 1997;29:278-293.
97. Rafaeloff R, Pittenger GL, Barlow SW, Qin XF, Yan B, Rosenberg L, Duguid WP, Vinjk AI. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 1997;99:2100-2109.
98. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O'Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000;97:7999-8004.
99. Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M, Chan L. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003;9:596-603.
100. Koike C, Friday RP, Nakashima I, Luppi P, Fung JJ, Rao AS, Starzl TE, Trucco M. Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene. Transplantation 2000;70:1275-1283.
101. Koike C, Fung JJ, Geller DA, Kannagi R, Libert T, Luppi P, Nakashima I, Profozich J, Rudert W, Sharma SB, Starzl TE, Trucco M. Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem 2002;277:10114-10120.
102. Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE, Cowell-Lucero JL, Wells KD, Colman A, Polejaeva IA, Ayares DL. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002;20:251-255.
103. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, Polejaeva IA, Monahan JA, Jobst PM, Sharma SM, Lamborn AE, Garst AS, Moore M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y, Ayares DL. Production of 1,3-Galactosyltransferase-Deficient Pigs. Science 2002;19:19.
104. Pietropaolo M, Becker DJ, LaPorte RE, Donnan JS, Riboni S, Rudert WA, Mazumdar S, Trucco M. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: The role of two HLA-DQ high-risk haplotypes. Diabetologia 2002;45:66-76.
105. Rosenbloom AL, Schatz DA, Krischer JP, Skyler JS, Becker DJ, Laporte RE, Libman I, Pietropaolo M, Dosch HM, Finberg L, Muir A, Tamborlane WV, Grey M, Silverstein JH, Malone JI. Therapeutic controversy: Prevention and treatment of diabetes in children. J Clin Endocrinol Metab 2000;85:494-522.
106. Wilson K, Eisenbarth GS. Immunopathogenesis and immunotherapy of type 1 diabetes. Annu Rev Med 1990;41:497-508.
107. Papoz L, Lenegre F, Hors J, Assan R, Vague P, Tchobroutsky G, Passa P, Charbonnel B, Mirouze J, Feutren G, Lallemand A, Eschwege E. Probability of remission in individual in early adult insulin dependent diabetic patients. Results from the Cyclosporine Diabetes French Study Group Diabete Metab 1990;16:303-310.
108. Shimada A, Imazu Y, Morinaga S, Funae O, Kasuga A, Atsumi Y, Matsuoka K. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care 1999;22:615-617.
109. Hamamoto Y, Tsuura Y, Fujimoto S, Nagata M, Takeda T, Mukai E, Fujita J, Yamada Y, Seino Y. Recovery of function and mass of endogenous beta-cells in streptozotocin-induced diabetic rats treated with islet transplantation. Biochem Biophys Res Commun 2001;287:104-109.
110. Rasmussen SB, Sorensen TS, Hansen JB, Mandrup-Poulsen T, Hornum L, Markholst H. Functional rest through intensive treatment with insulin and potassium channel openers preserves residual beta-cell function and mass in acutely diabetic BB rats. Horm Metab Res 2000;32:294-300.
111. Mayer A, Rharbaoui F, Thivolet C, Orgiazzi J, Madec AM. The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab 1999;84:2419-2424.
112. Finegood DT, Weir GC, Bonner-Weir S. Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats. Am J Physiol 1999;276:E822-827.
113. Chatenoud L, Thervet E, Primo J, Bach JF. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994;91:123-127.
114. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002;346:1692-1698.
115. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA. IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 1998;102:516-526.
116. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA. Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 1998;160:2684-2691.
117. Corbett JA, McDaniel ML. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 1995;181:559-568.
118. Heitmeier MR, Scarim AL, Corbett JA. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J Biol Chem 1997;272:13697-13704.
119. Lacy PE. The intraislet macrophage and type I diabetes. Mt Sinai J Med 1994;61:170-174.
120. McDaniel ML, Kwon G, Hill JR, Marshall CA, Corbett JA. Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med 1996;211:24-32.
121. Scarim AL, Arnush M, Hill JR, Marshall CA, Baldwin A, McDaniel ML, Corbett JA. Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans. Biochim Biophys Acta 1997;1361:313-320.
122. French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997;46:34-39.
123. Miyazaki T, Matsuda Y, Toyonaga T, Miyazaki J, Yazaki Y, Yamamura K. Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules. Proc Natl Acad Sci USA 1992;89:9519-9523.
124. Gerling IC, Serreze DV, Christianson SW, Leiter EH. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 1992;41:1672-1676.
125. Leykin I, Nikolic B, Sykes M. Mixed bone marrow chimerism as a treatment for autoimmune diabetes. Transplant Proc 2001;33:120.
126. Steptoe RJ, Thomson AW. Dendritic cells and tolerance induction. Clin Exp Immunol 1996;105:397-402.
127. Lee WC, Wan YH, Li W, Fu F, Sime PJ, Gauldie J, Thomson AW, Fung JJ, Lu L, Qian S. Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc 1999;31:1195.
128. Lu L, Gambotto A, Lee WC, Qian S, Bonham CA, Robbins PD, Thomson AW. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther 1999;6:554-563.
129. Takayama T, Nishioka Y, Lu L, Lotze MT, Tahara H, Thomson AW. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 1998;66:1567-1574.
130. Takayama T, Tahara H, Thomson AW. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells. Transplantation 1999;68:1903-1909.
131. Sharif S, Arreaza GA, Zucker P, Delovitch TL. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes. Ann NY Acad Sci 2002;958:77-88.
132. Naumov YN, Bahjat KS, Gausling R, Abraham R, Exley MA, Koezuka Y, Balk SB, Strominger JL, Clare-Salzer M, Wilson SB. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001;98:13838-13843.
133. Sharif S, Delovitch TL. Regulation of immune responses by natural killer T cells. Arch Immunol Ther Exp (Warsz) 2001;49: S23-31.
134. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001;7:1057-1062.
135. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001;7:1052-1056.
136. Pugliese A, Brown D, Garza D, Murchison D, Zeller M, Redondo M, Diez J, Eisenbarth GS, Patel DD, Ricordi C. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest 2001;107:555-564.
137. Gainer AL, Suarez-Pinzon WL, Min WP, Swiston JR, Hancock-Friesen C, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF. Improved survival of biolistically transfected mouse islet allografts expressing CTLA4-Ig or soluble Fas ligand. Transplantation 1998;66:194-199.
138. Gainer AL, Korbutt GS, Rajotte RV, Warnock GL, Elliott JF. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 1997;63:1017-1021.
139. Welsh N, Oberg C, Hellerstrom C, Welsh M. Liposome mediated in vitro transfection of pancreatic islet cells. Biomed Biochim Acta 1990;49:1157-1164.
140. Benhamou PY, Moriscot C, Prevost P, Rolland E, Halimi S, Chroboczek J. Standardization of procedure for efficient ex vivo gene transfer into porcine pancreatic islets with cationic liposomes. Transplantation 1997;63:1798-1803.
141. Giannoukakis N, Rudert WA, Ghivizzani SC, Gambotto A, Ricordi C, Trucco M, Robbins PD. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999;48:1730-1736.
142. Giannoukakis N, Rudert WA, Trucco M, Robbins PD. Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor. J Biol Chem 2000;275:36509-36513.
143. Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation 1997;64:1040-1049.
144. Yasuda H, Nagata M, Arisawa K, Yoshida R, Fujihira K, Okamoto N, Moriyama H, Miki M, Saito I, Hamada H, Yokono K, Kasuga M. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice (In Process Citation). J Clin Invest 1998;102:1807-1814.
145. Benhamou PY, Mullen Y, Shaked A, Bahmiller D, Csete ME. Decreased alloreactivity to human islets secreting recombinant viral interleukin 10. Transplantation 1996;62:1306-1312.
146. Judge TA, Desai NM, Yang Z, Rostami S, Alonso L, Zhang H, Chen Y, Markman JF, DeMateo RP, Barker CF, Naji A, Turka LA. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 1998;66:426-434.
147. von Herrath MG, Efrat S, Oldstone MB, Horwitz MS. Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc Natl Acad Sci USA 1997;94:9808-9813.
148. Weber M, Deng S, Kucher T, Shaked A, Ketchum RJ, Brayman KL. Adenoviral transfection of isolated pancreatic islets: A study of programmed cell death (apoptosis) and islet function. J Surg Res 1997;69:23-32.
149. Csete ME, Benhamou PY, Drazan KE, Wu L, McIntee DF, Afra R, Mullen Y, Busuttil RW, Shaked A. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 1995;59:263-268.
150. Raper SE, DeMatteo RP. Adenovirus-mediated in vivo gene transfer and expression in normal rat pancreas. Pancreas 1996;12:401-410.
151. Saldeen J, Curiel DT, Eizirik DL, Andersson A, Strandell E, Buschard K, Welsh N. Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes. Diabetes 1996;45:1197-1203.
152. Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets (In Process Citation). J Exp Med 1999;190:1135-1146.
153. Muruve DA, Manfro RC, Strom TB, Libermann TA. Ex vivo adenovirus-mediated gene delivery leads to long-term expression in pancreatic islet transplants. Transplantation 1997;64:542-546.
154. Becker TC, BeltrandelRio H, Noel RJ, Johnson JH, Newgard CB. Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 1994;269:21234-21238.
155. Contreras JL, Bilbao G, Smyth C, Eckhoff DE, Xiang XL, Jenkins S, Cartner S, Curiel DT, Thomas FT, Thomas JM. Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. Surgery 2001;130:166-174.
156. Alexander AM, Crawford M, Bertera S, Rudert WA, Takikawa O, Robbins PD, Trucco M. Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002;51:356-365.
157. Contreras JL, Bilbao G, Smyth CA, Jiang XL, Eckhoff DE, Jenkins SM, Thomas FT, Curiel DT, Thomas JM. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene. Transplantation 2001;71:1015-1023.
158. Shifrin AL, Auricchio A, Yu QC, Wilson J, Raper SE. Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia. Gene Ther 2001;8:1480-1489.
159. Uchikoshi F, Yang ZD, Rostami S, Yokoi Y, Capocci P, Barker CF, Naji A. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes 1999;48:652-657.
160. Moriscot C, Pattou F, Kerr-Conte J, Richard MJ, Lemarchand P, Benhamou PY. Contribution of adenoviral-mediated superoxide dismutase gene transfer to the reduction in nitric oxide-induced cytotoxicity on human islets and INS-1 insulin-secreting cells. Diabetologia 2000;43:625-631.
161. Guo Z, Shen J, Mital D, Hong Y, Alemany R, Zhong WW, Jensik SC, Williams JW. Efficient gene transfer and expression in islets by an adenoviral vector that lacks all viral genes. Cell Transplant 1999;8:661-671.
162. Giannoukakis N, Mi Z, Rudert WA, Gambotto A, Trucco M, Robbins P. Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. Gene Ther 2000;7:2015-2022.
163. Bertera S, Crawford ML, Alexander AM, Papworth GD, Watkins SC, Robbins PD, Trucco M. Gene Transfer of Manganese Superoxide Dismutase Extends Islet Graft Function in a Mouse Model of Autoimmune. Diabetes Diabetes 2003;52:387-393.
164. Flotte T, Agarwal A, Wang J, Song S, Fenjves ES, Inverardi L, Chesnut K, Afione S, Loiler S, Wasserfall C, Kapturczak M, Ellis T, Nick H, Atkinson M. Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 2001;50:515-520.
165. Yang YW, Kotin RM. Glucose-responsive gene delivery in pancreatic Islet cells via recombinant adeno-associated viral vectors. Pharm Res 2000;17:1056-1061.
166. Kapturczak M, Zolotukhin S, Cross J, Pileggi A, Molano RD, Jorgensen M, Byrne B, Flotte TR, Ellis T, Inverardi L, Ricordi C, Nick H, Atkinson M, Agarwal A. Transduction of human and mouse pancreatic islet cells using a bicistronic recombinant adeno-associated viral vector. Mol Ther 2002;5:154-160.
167. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A, Levine F. Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 1999;48:745-753.
168. Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 1998;9:2717-2726.
169. Ju Q, Edelstein D, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Brownlee M. Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 1998;41:736-739.
170. Giannoukakis N, Mi Z, Gambotto A, Eramo A, Ricordi C, Trucco M, Robbins P. Infection of intact human islets by a lentiviral vector. Gene Ther 1999;6:1545-1551.
171. Liu Y, Rabinovitch A, Suarez-Pinzon W, Muhkerjee B, Brownlee M, Edelstein D, Federoff HJ. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Hum Gene Ther 1996;7:1719-1726.
172. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt GS, Rajotte RV. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 1999;48:1223-1229.
173. Mi Z, Mai J, Lu X, Robbins PD. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol Ther 2000;2:339-347.
174. Embury J, Klein D, Pileggi A, Ribeiro M, Jayaraman S, Molano RD, Fraker C, Kenyon N, Ricordi C, Inverardi L, Pastori RL. Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 2001;50:1706-1713.
175. Rehman KK, Bertera S, Bottino R, Balamurugan AN, Mai JC, Mi Z, Trucco M, Robbins PD. Protection of islets by in situ peptide mediated transduction of the Ikappa B kinase (IKK) inhibitor nemo binding domain (NBD) peptide. J Biol Chem 2003;9:9.
176. Dupraz P, Rinsch C, Pralong WF, Rolland E, Zufferey R, Trono D, Thorens B. Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther 1999;6:1160-1169.
177. Zhou YP, Pena JC, Roe MW, Mittal A, Levisetti M, Baldwin AC, Pugh W, Ostrega D, Ahmed N, Bindokas VP, Philipson LH, Hanahan D, Thompson CB, Polonsky KS. Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am J Physiol Endocrinol Metab 2000;278:E340-351.
178. Tobiasch E, Gunther L, Bach FH. Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J Investig Med 2001;49:566-571.
179. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 2001;50:1983-1991.
180. Ye J, Laychock SG. A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta. Endocrinology 1998;139:4155-4163,
181. Carpenter L, Cordery D, Biden TJ. Inhibition of protein kinase C delta protects rat INS-1 cells against interleukin-1beta and streptozotocin-induced apoptosis. Diabetes 2002;51:317-324.
182. Dupraz P, Cottet S, Hamburger F, Dolci W, Felley-Bosco E, Thorens B. Dominant negative MyD88 proteins inhibit interleukin-1beta/interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells. J Biol Chem 2000;275:37672-37678.
183. Burkart V, Liu H, Bellmann K, Wissing D, Jaattela M, Cavallo MG, Pozzilli P, Briviba K, Kolb H. Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70. J Biol Chem 2000;275:19521-19528.
184. Xu B, Moritz JT, Epstein PN. Overexpression of catalase provides partial protection to transgenic mouse beta cells Free. Radic Biol Med 1999;27:830-837.
185. Benhamou PY, Moriscot C, Richard MJ, Beatrix O, Badet L, Pattou F, Kerr-Conte J, Chroboczek J, Lemarchand P, Halimi S. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 1998;41:1093-1100.
186. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB. Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 1998;101:1811-1820.
187. Deng S, Ketchum RJ, Yang ZD, Kucher T, Weber M, Shaked A, Naji A, Brayman KL. IL-10 and TGF-beta gene transfer to rodent islets: Effect on xenogeneic islet graft survival in naive and B-cell-deficient mice. Transplant Proc 1997;29:2207-2208.
188. Hao W, Palmer JP. Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells. J Interferon Cytokine Res 1995;15:1075-1081.
189. Kang SM, Schneider DB, Lin Z, Hanahan D, Dichek DA, Stock PG, Baekkeskov S. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction (see comments). Nat Med 1997;3:738-743.
190. Mathieu C, Casteels K, Bouillon R, Waer M. Protection against autoimmune diabetes in mixed bone marrow chimeras: Mechanisms involved. J Immunol 1997;158:1453-1457.
191. Girman P, Kriz J, Dovolilova E, Cihalova E, Saudek F. The effect of bone marrow transplantation on survival of allogeneic pancreatic islets with short-term tacrolimus conditioning in rats. Ann Transplant 2001;6:43-45.
192. Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000;95:2175-2182.
193. Li H, Colson YL, Ildstad ST. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Transplantation 1995;60:523-529.
194. Li H, Ricordi C, Demetris AJ, Kaufman CL, Korbanic C, Hronakes ML, Ildstad ST. Mixed xenogeneic chimerism (mouse + rat→mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. Transplantation 1994;57:592-598.
195. Rossini AA, Mordes JP, Greiner DL, Stoff JS. Islet cell transplantation tolerance. Transplantation 2001;72:S43-46.
196. Ali A, Garrovillo M, Jin MX, Hardy MA, Oluwole SF. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 2000;69:221-226.
197. Bertry-Coussot L, Lucas B, Danel C, Halbwachs-Mecarelli L, Bach JF, Chatenoud L, Lemarchand P. Long-term reversal of established autoimmunity upon transient blockade of the LFA-1/intercellular adhesion molecule-1 pathway. J Immunol 2002;168:3641-3648.
198. Georgiou HM, Brady JL, Silva A, Lew AM. Genetic modification of an islet tumor cell line inhibits its rejection. Transplant Proc 1997;29:1032-1033.
199. Lew AM, Brady JL, Silva A, Coligan JE, Georgiou HM. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen. Transplantation 1996;62:83-89.
200. Weber CJ, Hagler MK, Chryssochoos JT, Larsen CP, Pearson TC, Jensen P, Kapp JA, Linsley PS. CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice. Transplant Proc 1996;28:821-823.
201. Brady JL, Lew AM. Additive efficacy of CTLA4Ig and OX40Ig secreted by genetically modified grafts. Transplantation 2000;69:724-730.
202. Sutherland RM, Brady JL, Georgiou HM, Thomas HE, Lew AM. Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts. Transplantation 2000;69:1806-1812.
203. Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A, Powers M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Ellis TM, Flotte TR, Atkinson MA. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci USA 2001;98:13913-13918.
204. Ko KS, Lee M, Koh JJ, Kim SW. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Mol Ther 2001;4:313-316.
205. Koh JJ, Ko KS, Lee M, Han S, Park JS, Kim SW. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther 2000;7:2099-2104.
206. Yang Z, Chen M, Wu R, Fialkow LB, Bromberg JS, McDuffie M, Naji A, Nadler JL. Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol 2002;168:6479-6485.
207. Zipris D, Karnieli E. A single treatment with IL-4 via retrovirally transduced lymphocytes partially protects against diabetes in Bio-Breeding (BB) rats. Jop 2002;3:76-82.
208. Chang Y, Prud'homme GJ. Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity. J Gene Med 1999;1:415-423.
209. Prud'homme GJ, Chang Y. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein. Gene Ther 1999;6:771-777.
210. Piccirillo CA, Chang Y, Prud'homme GJ. TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol 1998;161:3950-3956.
211. Balasa B, Boehm BO, Fortnagel A, Karges W, Van Gunst K, Jung N, Camacho SA, Webb SR, Sarvetnick N. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. Clin Immunol 2001;99:241-252.
212. Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase. Diabetologia 2002;45:668-676.
213. Efrat S, Serreze D, Svetlanov A, Post CM, Johnson EA, Herold K, Horwitz M. Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 2001;50:980-984.
214. Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-837.
215. Polanski M, Melican NS, Zhang J, Weiner HL. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a cotransfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J Autoimmun 1997;10:339-346.
216. Bergerot I, Arreaza GA, Cameron MJ, Burdick MD, Strieter RM, Chensue SW, Chakrabarti S, Delovitch TL. Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. Diabetes 1999;48:1720-1729.
217. Prud'homme GJ, Chang Y, Li X. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Hum Gene Ther 2002;13:395-406.